The U.S. Food and Drug Administration has approved Journey Medical's Emrosi (minocycline hydrochloride) for the treatment of ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

This approval is a transformational milestone for both Journey Medical and the dermatology community, as Emrosi has the potential to become the best-in-class oral medication and standard of care to ...

Discover a study regime that included a treatment serum, a redness-reducing moisturizer, and sunscreen that showed promising ...

Journey Medical's new rosacea treatment will rival industry giant Galderma's Oracea in the treatment of rosacea.

Journey Medical now intends “to establish Emrosi as a new standard of care in the treatment of rosacea ... to become the best-in-class oral medication to treat the condition”.

Journey Medical (NASDAQ:DERM) shares are trading higher Monday after the company announced the U.S. Food and Drug ...

For a list of products with lower levels of benzene as well as alternatives for managing skin blemishes, you may wish to read ...

One study looked at 1,000 people who took a biologic medication and another 1,000 who got a placebo. In the biologic group, 770 reported a side effect, which was slightly more than the 724 in the ...

you can take medications that reduce the number of future headaches (preventive treatment). An over-the-counter (OTC) pain reliever may ease mild to moderate migraines but can't prevent them. Some ...

We’re both over 65 and already had signed up for Medicare, but suddenly we had to consider picking a Medicare Part D plan for prescription drugs. KFF reports that at least 53 million Americans ...